HOWL - Werewolf Therapeutics Inc
IEX Last Trade
2.14
-0.080 -3.738%
Share volume: 150,977
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.22
-0.08
-3.60%
Summary score
12%
Profitability
8%
Dept financing
9%
Liquidity
75%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.68%
Return on assets
-7.46%
Return on sales
-559.56%
Return on invested capital
1114.04%
Total debt ratio
23.21%
Debt ratio change over timeo
-1.27%
Current Ratio
11.31%
Quick Ratio
11.31%
Cash Position Ratio
10.96%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.05%
Return on assets
-6.4%
Return on sales
-852.11%
Return on invested capital
-60.98%
Total debt ratio
35.58%
Debt ratio change over timeo
-1.45%
Current Ratio
8.33%
Quick Ratio
8.33%
Cash Position Ratio
7.92%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-13.77%
Return on assets
-9.66%
Return on sales
-2312.94%
Return on invested capital
-114.83%
Total debt ratio
33.79%
Debt ratio change over time
-1.48%
Current Ratio
6.71%
Quick Ratio
6.71%
Cash Position Ratio
6.56%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-93.59%
Return on assets
-94.85%
Return on sales
607.39%
Return on invested capital
10.57%
Total debt ratio
-127.45%
Debt ratio change over time
-1.27%
Current Ratio
-6.91%
Quick Ratio
-6.91%
Cash Position Ratio
-6.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HOWL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -20.68% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.46% | 2.76% | 3.15% | 5.62% |
| Return on sales | -559.56% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 1114.04% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 59% | 56% |
| Total debt ratio | 23.21% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.27% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 8.33% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.33% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.92% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 10% | 23% |
| Short-term ratios | HOWL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.05% | 13.77% | 13.25% | 3.8% |
| Return on assets | -6.4% | 2.43% | 1.89% | 3.09% |
| Return on sales | -852.11% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -60.98% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 35.58% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.45% | 46.38% | -72.08% | 1.51% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 8.33% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.33% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.92% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 16% | 39% |